IL6 and macular holes: However, vitreous VEGF concentration in control patients did not show any significant variation with IL-6–174G/C polymorphism (Figure 4) Mean vitreous concentrations of IL-6 and VEGF were significantly higher in patients in the proliferative stage than control patients with macular holes for all IL-6-174G/C genotypes (Table 7).